Pinitol, isolated from soybeans, may bebeneficial in reducing cardiovascular risk intype 2s, according to Korean researchers.
In a randomized study, a total of30 type 2 patients received 600-mg oraldoses of soybean-derived pinitol orplacebo twice daily for 13 weeks.
Pinitol significantly decreased meanfasting plasma glucose, insulin,fructosamine and A1C. In addition,pinitol decreased total cholesterol,LDL cholesterol, systolic and diastolicblood pressure and increasedHDL cholesterol.
—European Journalof Clinical Nutrition, November 2004